|
US5688787A
(en)
|
1991-07-23 |
1997-11-18 |
Schering Corporation |
Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof
|
|
US5631356A
(en)
|
1992-04-03 |
1997-05-20 |
Gist-Brocades, N.V. |
Selective N-acylation of amino alcohols
|
|
LT3595B
(en)
|
1993-01-21 |
1995-12-27 |
Schering Corp |
Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
|
|
US5631365A
(en)
|
1993-09-21 |
1997-05-20 |
Schering Corporation |
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
FR2710337B1
(fr)
|
1993-09-23 |
1995-12-08 |
Gerard Coquerel |
Procédé de dédoublement de deux antipodes optiques par entraînement polythermique programmé et autoensemencé.
|
|
US5624920A
(en)
|
1994-11-18 |
1997-04-29 |
Schering Corporation |
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5633246A
(en)
|
1994-11-18 |
1997-05-27 |
Schering Corporation |
Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
|
|
US5656624A
(en)
|
1994-12-21 |
1997-08-12 |
Schering Corporation |
4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
|
|
US5756470A
(en)
|
1996-10-29 |
1998-05-26 |
Schering Corporation |
Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
HRP20030498A2
(en)
|
2000-12-21 |
2005-04-30 |
Aventis Pharma Deutschland Gmbh |
Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism
|
|
TWI291957B
(en)
|
2001-02-23 |
2008-01-01 |
Kotobuki Pharmaceutical Co Ltd |
Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
|
|
US20080249040A1
(en)
|
2001-05-18 |
2008-10-09 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of sterol regulatory element binding protein 1 (SREBP1) gene expression using short interfering nucleic acid (siNA)
|
|
US20050014177A1
(en)
|
2003-05-19 |
2005-01-20 |
Koustubh Ranade |
Human sterol response element binding protein 1 (SREBP1) single nucleotide polymorphisms
|
|
AU2007297388A1
(en)
*
|
2006-09-18 |
2008-03-27 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of scap and therapeutic uses thereof
|
|
JP2018507234A
(ja)
*
|
2015-03-04 |
2018-03-15 |
メディベイション テクノロジーズ エルエルシー |
肝臓線維症、コレステロールの上昇およびインスリン抵抗性を処置する際における使用のためのｓｒｅｂｐ遮断薬
|
|
WO2017100542A1
(en)
|
2015-12-10 |
2017-06-15 |
Alnylam Pharmaceuticals, Inc. |
Sterol regulatory element binding protein (srebp) chaperone (scap) irna compositions and methods of use thereof
|
|
WO2019141723A1
(en)
|
2018-01-18 |
2019-07-25 |
Roche Innovation Center Copenhagen A/S |
Antisense oligonucleotides targeting srebp1
|